




Charité Entrepreneurship Summit 2012
|
Edward S. AndrleEd is Vice President of Business Development and Strategy at the Sorin Group. He is also a director at MD Start SA in Lausanne/ Switzerland. Prior to Sorin, Mr. Andrle co-founded, developed, and sold three medical device companies in the Minneapolis area. |
|
Michael BrehmMichael is managing director at Rebate Networks GmbH and investor in Daily Deal GmbH as well as other companies. Earlier, he co-founded StudiVZ group, now one of the largest internet based social networks with approx. 15 Mio users. |
|
Anne GloverAnne is a co-founder and chief executive of Amadeus Capital Partners Ltd., the management company that provides investment services to the Amadeus venture capital funds. |
|
Simon E. MoroneySimon is a co-founder of MorphoSys, one of the most successful biotech companies in Germany, and its CEO. |
|
Alexander OsterwalderAlexander works as an independent author, speaker, and advisor with a focus on business model innovation, strategic management, and management innovation. His book “Business Model Generation” is an international bestseller. |
|
Martin RothmanMartin is a world-renowned interventional cardiologist and Vice President, Medical Affairs for Coronary and Peripheral Vascular Business, at Medtronic. Previously he worked for the UK National Health Service for almost 40 years, including a decade spent as director of cardiac research and development at the London Chest Hospital. |
|
Stephan SchambachStephan is a true visionary among German entrepreneurs: Among the first to recognize the potential of the e-commerce industry, he independently invented some of today's essential industry standards. He is the Founder and Chairman of Demandware. Previously, he founded Intershop Communications AG, one of the first software start-ups in East Germany after the Berlin Wall came down, and led it to its successful NASDAQ listing. |
|
Halle TeccoHalle directs Rock Health, the first seed-accelerator for health apps. She works directly with startups, helping them develop sustainable business models and connecting them with strategic partners. |
|
Sander van DeventerSander is general partner at the Dutch venture capital firm Forbion Capital Partners. He is also professor of translational gastroenterology at Leiden University Medical Center and has extensive experience in translational research with particular emphasis on drug development. |
|
Stefan VilsmeierStefan is one of the leading medical device entrepreneurs in Germany. He founded Brainlab in 1989 and spearheaded new developments in neuro-navigation and radiotherapy. Today Brainlab AG is a global corporation that employs 1,000 people worldwide, generating more than 50 percent of its revenues in the US, and has partnerships with leading healthcare companies. In December 2002, the World Economic Forum (WEF) selected Stefan Vilsmeier as one of their 'Global Leaders for Tomorrow 2003'. |
|
Bernd WegenerBernd Wegener, a veterinarian, founded and led B.R.A.H.M.S Diagnostica for many years, starting with a management buyout and ending with a successful sale to Thermo Fisher Scientific in 2009. Before that, he was active in various leading and directing roles at Boehringer Ingelheim KG, the Degussa pharmacology group, Marion Merrell Dow GmbH, and Henning Berlin GmbH. He is an active investor and serves on several boards. |
|
Chuck WilsonChuck serves as the Global Head of Strategic Alliances at the Novartis Institutes for BioMedical Research, leading a group responsible for research partnering at Novartis. Partnering efforts include academic relationships to understand disease processes, biotech collaborations to access drug discovery technologies, and in-licensing of compounds prior to clinical proof-of-concept. |